Summary & Overview
CPT 1158F: Unspecified CPT Service
CPT code 1158F is a Current Procedural Terminology entry for which no descriptive summary was provided in the source input. As a named CPT code it represents a specific clinical or administrative service used in professional billing. Nationally, accurate identification of CPT codes is critical for claims processing, payment consistency, and clinical documentation alignment. This publication addresses CPT code 1158F, highlighting payer coverage considerations and the types of information readers should expect when evaluating an unfamiliar or undocumented code.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The content is designed to help billing managers, compliance officers, and clinical coders understand what to look for when a CPT code lacks an available summary: payer policies, reimbursement benchmarks, clinical context, and any applicable policy updates.
Readers will learn where to find authoritative descriptions, how to frame internal reviews of undocumented codes, and what typical follow-up steps to expect from major payers and Medicare. Where specific data elements were not provided in the source, the publication notes that those items are not available in the input and outlines next-step resources for obtaining definitive code descriptions from coding manuals and payer policy documents.
Billing Code Overview
CPT code 1158F has no summary available in the source description. Based on the code label, this entry represents a discrete billing entry within the CPT coding system.
-
Service type: Data not available in the input.
-
Typical site of service: Data not available in the input.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old male with multiple actinic keratoses presents to a dermatology clinic for lesion evaluation and treatment. The patient is on anticoagulation for atrial fibrillation and reports a single enlarging hyperkeratotic lesion on the dorsal hand that occasionally bleeds. After clinical assessment and dermoscopic evaluation, the dermatologist determines that the lesion is suspicious for squamous cell carcinoma in situ (Bowen disease) versus hypertrophic actinic keratosis and recommends destruction of the lesion with cryotherapy or electrosurgical destruction in an outpatient dermatology procedure room. The typical workflow includes informed consent, local anesthesia as indicated, lesion preparation and measurement, destruction technique selection (liquid nitrogen cryotherapy or electrodessication and curettage), hemostasis, wound care instructions, and documentation of lesion size, location, technique, number of lesions treated, and post-procedure status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service on the same day as a procedure | Use when an E/M visit is medically necessary and documented separately from the procedure on the same day |
26 | Professional component | Use when reporting only the physician’s professional component separate from a facility